Skip to main content
Christopher Goss, MD, Pulmonology, Seattle, WA

Christopher Hooper Goss MD

Pulmonology•Seattle, WA

Pleural Disease

Professor, Medicine and Pediatrics, University of Washington School of Medicine

Join to view full profile

  • PO Box# 1959Seattle, WA 98195

  • Phone+1 206-598-4615

  • Fax+1 206-598-7214

Dr. Goss is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Goss' full profileAlready have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Critical Care Medicine (Internal Medicine), 2001
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1992 - 1995
  • University of Colorado School of Medicine Anschutz Medical Campus
    University of Colorado School of Medicine Anschutz Medical CampusClass of 1992

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1997 - 2026
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Association Between Heroin Inhalation and Early Onset Emphysema
    The Association Between Heroin Inhalation and Early Onset EmphysemaJuly 17th, 2020
  • Using 1 Germ to Fight Another When Today’s Antibiotics Fail
    Using 1 Germ to Fight Another When Today’s Antibiotics FailFebruary 26th, 2019
  • New Approach Against Antibiotic-Resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial
    New Approach Against Antibiotic-Resistant Bacteria in CF Patients Shows Promise in Phase 1 TrialOctober 9th, 2018

Grant Support

  • Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator EraSEATTLE CHILDREN'S HOSPITAL2010–2030
  • Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator EraSEATTLE CHILDREN'S HOSPITAL2010–2030
  • Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator EraSEATTLE CHILDREN'S HOSPITAL2010–2030
  • A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study).SEATTLE CHILDREN'S HOSPITAL2020–2027
  • Early Intervention In Pulmonary Exacerbation In CFNational Heart, Lung, And Blood Institute2010–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Christopher Goss, Dr. Christopher Goss, MD, Dr. C Goss, Dr. Christopher Hooper Goss